Cargando…

Development and validation of a short-term breast health measure as a supplement to screening mammography

BACKGROUND: There is a growing body of evidence to support tears as a non-traditional biological fluid in clinical laboratory testing. In addition to the simplicity of tear fluid processing, the ability to access key cancer biomarkers in high concentrations quickly and inexpensively is significantly...

Descripción completa

Detalles Bibliográficos
Autores principales: Daily, Anna, Ravishankar, Prashanth, Wang, Wanyi, Krone, Ryan, Harms, Steve, Klimberg, V. Suzanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9594920/
https://www.ncbi.nlm.nih.gov/pubmed/36284356
http://dx.doi.org/10.1186/s40364-022-00420-1
_version_ 1784815539276742656
author Daily, Anna
Ravishankar, Prashanth
Wang, Wanyi
Krone, Ryan
Harms, Steve
Klimberg, V. Suzanne
author_facet Daily, Anna
Ravishankar, Prashanth
Wang, Wanyi
Krone, Ryan
Harms, Steve
Klimberg, V. Suzanne
author_sort Daily, Anna
collection PubMed
description BACKGROUND: There is a growing body of evidence to support tears as a non-traditional biological fluid in clinical laboratory testing. In addition to the simplicity of tear fluid processing, the ability to access key cancer biomarkers in high concentrations quickly and inexpensively is significantly enhanced. Tear fluid is a dynamic environment rich in both proteomic and genomic information, making it an ideal medium for exploring the potential for biological testing modalities. METHODS: All protocols involving human subjects were reviewed and approved by the University of Arkansas IRB committee (13-11-289) prior to sample collection. Study enrollment was open to women ages 18 and over from October 30, 2017-June 19, 2019 at The Breast Center, Fayetteville, AR and Bentonville, AR. Convenience sampling was used and samples were age/sex matched, with enrollment open to individuals at any point of the breast health continuum of care. Tear samples were collected using the Schirmer strip method from 847 women. Concentration of selected tear proteins were evaluated using standard sandwich ELISA techniques and the resulting data, combined with demographic and clinical covariates, was analyzed using logistic regression analysis to build a model for classification of samples. RESULTS: Logistic regression analysis produced three models, which were then evaluated on cases and controls at two diagnostic thresholds and resulted in sensitivity ranging from 52 to 90% and specificity from 31 to 79%. Sensitivity and specificity variation is dependent on the model being evaluated as well as the selected diagnostic threshold providing avenues for assay optimization. CONCLUSIONS AND RELEVANCE: The work presented here builds on previous studies focused on biomarker identification in tear samples. Here we show successful early classification of samples using two proteins and minimal clinical covariates. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40364-022-00420-1.
format Online
Article
Text
id pubmed-9594920
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-95949202022-10-26 Development and validation of a short-term breast health measure as a supplement to screening mammography Daily, Anna Ravishankar, Prashanth Wang, Wanyi Krone, Ryan Harms, Steve Klimberg, V. Suzanne Biomark Res Research BACKGROUND: There is a growing body of evidence to support tears as a non-traditional biological fluid in clinical laboratory testing. In addition to the simplicity of tear fluid processing, the ability to access key cancer biomarkers in high concentrations quickly and inexpensively is significantly enhanced. Tear fluid is a dynamic environment rich in both proteomic and genomic information, making it an ideal medium for exploring the potential for biological testing modalities. METHODS: All protocols involving human subjects were reviewed and approved by the University of Arkansas IRB committee (13-11-289) prior to sample collection. Study enrollment was open to women ages 18 and over from October 30, 2017-June 19, 2019 at The Breast Center, Fayetteville, AR and Bentonville, AR. Convenience sampling was used and samples were age/sex matched, with enrollment open to individuals at any point of the breast health continuum of care. Tear samples were collected using the Schirmer strip method from 847 women. Concentration of selected tear proteins were evaluated using standard sandwich ELISA techniques and the resulting data, combined with demographic and clinical covariates, was analyzed using logistic regression analysis to build a model for classification of samples. RESULTS: Logistic regression analysis produced three models, which were then evaluated on cases and controls at two diagnostic thresholds and resulted in sensitivity ranging from 52 to 90% and specificity from 31 to 79%. Sensitivity and specificity variation is dependent on the model being evaluated as well as the selected diagnostic threshold providing avenues for assay optimization. CONCLUSIONS AND RELEVANCE: The work presented here builds on previous studies focused on biomarker identification in tear samples. Here we show successful early classification of samples using two proteins and minimal clinical covariates. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40364-022-00420-1. BioMed Central 2022-10-25 /pmc/articles/PMC9594920/ /pubmed/36284356 http://dx.doi.org/10.1186/s40364-022-00420-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Daily, Anna
Ravishankar, Prashanth
Wang, Wanyi
Krone, Ryan
Harms, Steve
Klimberg, V. Suzanne
Development and validation of a short-term breast health measure as a supplement to screening mammography
title Development and validation of a short-term breast health measure as a supplement to screening mammography
title_full Development and validation of a short-term breast health measure as a supplement to screening mammography
title_fullStr Development and validation of a short-term breast health measure as a supplement to screening mammography
title_full_unstemmed Development and validation of a short-term breast health measure as a supplement to screening mammography
title_short Development and validation of a short-term breast health measure as a supplement to screening mammography
title_sort development and validation of a short-term breast health measure as a supplement to screening mammography
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9594920/
https://www.ncbi.nlm.nih.gov/pubmed/36284356
http://dx.doi.org/10.1186/s40364-022-00420-1
work_keys_str_mv AT dailyanna developmentandvalidationofashorttermbreasthealthmeasureasasupplementtoscreeningmammography
AT ravishankarprashanth developmentandvalidationofashorttermbreasthealthmeasureasasupplementtoscreeningmammography
AT wangwanyi developmentandvalidationofashorttermbreasthealthmeasureasasupplementtoscreeningmammography
AT kroneryan developmentandvalidationofashorttermbreasthealthmeasureasasupplementtoscreeningmammography
AT harmssteve developmentandvalidationofashorttermbreasthealthmeasureasasupplementtoscreeningmammography
AT klimbergvsuzanne developmentandvalidationofashorttermbreasthealthmeasureasasupplementtoscreeningmammography